KM Financial Solutions | UPDATE 3-Valeant profit beats forecasts on Bausch & Lomb strength
3111
post-template-default,single,single-post,postid-3111,single-format-standard,qode-quick-links-1.0,ajax_fade,page_not_loaded,,qode_grid_1300,footer_responsive_adv,hide_top_bar_on_mobile_header,qode-child-theme-ver-1.0.0,qode-theme-ver-11.2,qode-theme-bridge,wpb-js-composer js-comp-ver-5.2.1,vc_responsive
 

UPDATE 3-Valeant profit beats forecasts on Bausch & Lomb strength

UPDATE 3-Valeant profit beats forecasts on Bausch & Lomb strength

Nov 7 (Reuters) – Valeant Pharmaceuticals International Inc
reported a better-than-expected quarterly profit on
strength in its Bausch and Lomb eye care business, sending its
shares up more than 15 percent.

No Comments

Post A Comment